The only FDA-approved closure device for use following
cardiac ablations*Proven
VASCADE MVP was evaluated in the AMBULATE pivotal trial. AMBULATE was a multicenter, randomized clinical trial with 204 patients randomized 1:1 to VASCADE MVP or manual compression.
Read the full JACC EP
published article
1 As demonstrated in the AMBULATE Pivotal Trial. | * Cardiac ablations requiring two or more access sites within the same limb. See VASCADE MVP IFU 3972 Indications for Use